Supreme Court takes up birth control coverage dispute
The justices will hear challenges to the contraception mandate from for profit firms led by Hobby Lobby and Conestoga Wood, with Autocam and medical groups weighing in on whether for profit entities can claim religious exemptions. Arguments likely in March, decision by June, amid a broad clash over the Religious Freedom Restoration Act and corporate personhood.
MENTIONED IN THIS ARTICLE
Conestoga Wood
FDA
Hobby Lobby
Autocam
Physicians For Reproductive Health
American College of Obstetricians and Gynecologists
American Association of Pro-Life Obstetricians and Gynecologists
The
Catholic Medical Association
Washington
Supreme Court
Barack Obama
Obama
Hobby Lobby Inc
Arts and Crafts
Citizens United
Methane Emissions Exceed EPA Estimates by Fifty Percent
A comprehensive study finds U.S. methane emissions in 2008 at about 49 million tons, 50 percent higher than EPA estimates, driven largely by Texas Oklahoma and Kansas. The research notes methane's strong global warming potential and cites livestock leaks and oil gas operations as major sources.
MENTIONED IN THIS ARTICLE
Washington
United States
Texas
Oklahoma
Kansas
National Academy of Science
U.S
U.S. Environmental Protection Administration
European Commission
Anna Michalak
Carnegie Institution For Science
Stanford
Calif
EPA
Alisha Johnson
FDA orders halt of 23andMe DNA test sales
The FDA demands 23andMe stop selling its personalized DNA test kits citing lack of demonstrated safety and effectiveness. The warning notes extensive meetings and exchanges but says the firm has not proven analytical or clinical validity of its test for over 250 diseases and that results could lead to unnecessary medical care.
MENTIONED IN THIS ARTICLE
Washington
Food and Drug Administration
23andMe
FDA
Silicon Valley
23and Me
Mountain View
Calif
Anne Wojcicki
Google
Sergey Brin
Brin
FDA lifts safety limits on Avandia diabetes drug
The FDA ends the 2010 restrictions on Avandia after a new analysis shows no greater heart attack risk versus other diabetes drugs. The change allows wider pharmacy access, removes the required registry, and marks a setback for safety advocates while GlaxoSmithKline welcomes the decision.
MENTIONED IN THIS ARTICLE
Washington
Food and Drug Administration
U.S
FDA
FDA Drug Center
Janet Woodcock
Woodcock
Con
Nissen
Record
Glaxo
Duke University
Duke
Also Mentioned on This Page
Mark Sherman
Associated Press
Green
Mardel Christian
10Th
U.S. Circuit Court of Appeals
Mardel
Conestoga Wood Specialties Corp
Pennsylvania
Autocam Corp
Denver
Elyria
Erie
ErieMetal
Matthew Perrone
Gress
Steven Nissen
Cleveland Clinic
Department of Cardiology
This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!